Solventum Corporation
Solventum Corporation is a healthcare company with significant exposure to federal healthcare policy, evidenced by $6.0M in annual payments to doctors and a single congressional sale of its stock.
BusinessWhat SOLV does
Solventum Corporation operates in the healthcare sector. Its business model and specific revenue lines are not detailed in the provided context, but its activity is concentrated in areas subject to federal healthcare regulation and reimbursement.
12 months past · 3 months futureSOLV activity timeline
Executive Branch ConflictsSOLV held by Trump-administration officials
Lifetime Government AwardsSOLV federal contracts
SOLV doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding SOLV
Politicians Trading SOLVMembers of Congress with recent SOLV positions
Congressional TradesWho in Congress is trading SOLV
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting SOLVLive legislation impacting this stock
Political ProfileWhere SOLV sits in Washington
[object Object]
STRUCTURAL: High regulatory density (8 healthcare bills with material revenue impact) and $5.96M in annual doctor payments create compliance overhead and policy risk. EVIDENTIARY: Minimal direct political activity; no federal contracts, lobbying spend, or executive branch holdings. A single director buy ($100.3K) and a single congressional sale are weak, opposing signals. Net: Structural policy risk is not offset by evidentiary political engagement or alignment.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payments under transparency lawsHHS/CMS"`get_political_influence.doctor_payments[0]` shows 24,433 payments totaling $5.96M in 2024."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Capitol Hill AlliesChampions & critics
Congressional champions
- No specific congressional champions identified.
Congressional critics
- Unknown Unknown
Live signals + predictions for SOLV — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades SOLV
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord